Taghleef launches film effective against coronavirus

Derprosa Antimicrobial is the new designation of Derprosa Bacterstop film. Taghleef Industries set out to verify its effectiveness for viruses by testing with different types of coronavirus. The laminating film was first tested with the feline coronavirus due to the availability and capabilities of independent specialized laboratories. Finally, the film was tested with the human coronavirus SARS-CoV2. 

According to the company, in both trials, the performance of Derprosa Antimicrobial films has been outstanding. Tests have shown that after 24 hours, there is a reduction of more than 84 percent of coronavirus SARS-CoV-2 on its surface area compared to a laminating film without our antimicrobial agent.

According to Taghleef, test results proved that Derprosa Antimicrobial inhibits proliferation and neutralizes bacteria and viruses' survival on non-porous surfaces. It has been specifically tested by independent laboratories against the Methicillin-resistant bacteria Staphylococcus Aureus (MRSA) and Escherichia Coli (E-Coli), the feline coronavirus (FCoV), and human coronavirus (SARS-CoV-2). 

Derprosa Gloss Antimicrobial and Derprosa Matte Antimicrobial provide a glossy or matte finish and the same properties, machinability, and technical performance as other traditional films, including wet, thermal, and thermal digital lamination versions. Food contact approved (certified in Europe). The antimicrobial effect is long-lasting, odorless, harmless to humans, and safe. 

‘Our antimicrobial technology is also available across other Taghleef Industries’ film ranges designed for label applications and flexible packaging. It is, without a doubt, a cross-cutting and versatile solution suitable for multiple applications that puts into practice one of the main advantages of Taghleef Group: the ability to widespread across different industries its most valuable innovations for customers, brands, and our society,’ said the company in a statement.